In 2012 we discovered that almost all premature infants in hospital NICUs do not receive the lifesaving benefits of an exclusive human milk diet.
A commonly accepted belief is that human milk is expensive and in short supply, but we continue to be overwhelmed by the presence of moms with excess milk who want to help babies in need. We set out to find a solution that connected these moms to premature and at-risk infants in need, changing lives forever.
Focused on outcomes with a philosophy centered around babies and mothers.
"It's about keeping the good stuff in while getting the bad stuff out. That's what our innovative technology, Gentle-UHT, allows us to do."
The journey to provide premature babies with a reliable, safe, and abundant source of human milk begins.
How can human milk become more affordable for hospitals? Can milk waste in NICUs be avoided? Is there a way for babies to go home with a supply of milk, so they don't have to be switched to formula so early?
Positioning LactaLogics to be a category leader, our Core Processing and Fortification patents are filed.
Utilizing Tetra Pak’s aseptic ultra-high-temperature facility, we processed our human milk products at commercial scale three times.
In our first run, we validated Gentle-UHT as able to offer superior retention of proteins, immune factors, and HMOs while protecting the milk against dangerous bacteria, viruses, molds, and spores. We created flexible calorie and protein amounts in our second run, allowing us to move forward with our in-hospital and outpatient pilot programs.
Our third run further pushed our methodologies in collecting breast milk from donors in a way that is safe and supported, as well as how we processed the milk.
Because these products were processed in an FDA-approved plant, they were able to be utilized in our Neonatal Intensive Care Unit (NICU) and outpatient pilot programs.
As we validated our processing and fortification patents, we also optimized how to best prioritize moms who have excess milk. We developed our holistic donor care approach, which includes our Fast-Reimburse Program.
Our commitment to holistic donor care was defined while streamlined reimbursement was established, ensuring prompt payment to donors.
We launched our year-long pilot program in Renown Regional Medical Center Level III NICU.
Feeding over 22,000 oz of Gentle-UHT human milk to very low birth weight (VLBW) patients, we validated how NICUs can save money and limit waste.
We believe that our formulations should be optimized by doctors, researchers, and dietitians, not companies. Our CSAB ensures LactaLogics remains focused on outcomes.
The five-member board is chaired by Dr. William Rhine and includes Bruce German, Ph.D., Dr. Kushal Bhakta, Dr. Camilia R. Martin, Dr. Steven McElroy, and Dr. Jonathan Palma. Together, they bring extensive experience, dedicated to making human milk-based products more readily available to all infants.
NEC Society does not endorse any product or company, and does not create, sponsor, or authorize the content of any communications, surveys, programs, or incentives from any company. NEC Society is a registered word mark of its owner and its use does not imply any affiliation, endorsement, or sponsorship by them.
